(DORM) Dorman Products - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2582781009
Engine, Suspension, Body, Electronics, Hardware
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 32.8% |
| Value at Risk 5%th | 48.4% |
| Relative Tail Risk | -10.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.20 |
| Alpha | -19.62 |
| CAGR/Max DD | 0.37 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.521 |
| Beta | 0.707 |
| Beta Downside | 0.698 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.85% |
| Mean DD | 12.43% |
| Median DD | 11.75% |
Description: DORM Dorman Products November 09, 2025
Dorman Products (NASDAQ:DORM) is a U.S.–based supplier of replacement and upgrade parts for the motor-vehicle aftermarket, serving light-duty, heavy-duty, and specialty-vehicle segments. Its catalog spans engine, under-car, steering-suspension, body, electronics, and hardware components, marketed under brands such as DORMAN, HELP! and SuperATV, and includes OE-FIX solutions that target both original-equipment manufacturers and independent repair shops.
Key data points (FY 2023): revenue of $2.1 billion, operating margin of ≈ 6.5 %, and a 4 % year-over-year growth in aftermarket sales driven by higher vehicle-age penetration and an expanding UTV market. The segment’s performance is closely linked to macro trends such as vehicle miles traveled (VMT) growth, which historically adds ~0.5 % to aftermarket demand per percentage-point VMT increase, and the ongoing shift toward electric-vehicle (EV) platforms, where Dorman is beginning to develop EV-specific thermal-management and electronic modules.
If you want a data-rich, unbiased view of Dorman’s valuation and risk profile, a quick look at ValueRay’s analyst dashboard can help you spot any gaps in the public narrative before you dive deeper.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (247.1m TTM) > 0 and > 6% of Revenue (6% = 127.6m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -3.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.05% (prev 38.32%; Δ 8.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 143.4m <= Net Income 247.1m (YES >=105%, WARN >=100%) |
| Net Debt (499.3m) to EBITDA (416.2m) ratio: 1.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.8m) change vs 12m ago 0.14% (target <= -2.0% for YES) |
| Gross Margin 41.88% (prev 39.54%; Δ 2.33pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 86.49% (prev 83.32%; Δ 3.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.67 (EBITDA TTM 416.2m / Interest Expense TTM 30.9m) >= 6 (WARN >= 3) |
Altman Z'' 6.62
| (A) 0.39 = (Total Current Assets 1.52b - Total Current Liabilities 516.7m) / Total Assets 2.55b |
| (B) 0.53 = Retained Earnings (Balance) 1.36b / Total Assets 2.55b |
| (C) 0.15 = EBIT TTM 360.7m / Avg Total Assets 2.46b |
| (D) 1.26 = Book Value of Equity 1.35b / Total Liabilities 1.07b |
| Total Rating: 6.62 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.18
| 1. Piotroski 6.0pt |
| 2. FCF Yield 2.34% |
| 3. FCF Margin 4.96% |
| 4. Debt/Equity 0.37 |
| 5. Debt/Ebitda 1.20 |
| 6. ROIC - WACC (= 7.27)% |
| 7. RoE 17.93% |
| 8. Rev. Trend 90.22% |
| 9. EPS Trend 70.33% |
What is the price of DORM shares?
As of December 03, 2025, the stock is trading at USD 129.10 with a total of 195,309 shares traded.
Over the past week, the price has changed by -4.71%, over one month by -3.35%, over three months by -19.59% and over the past year by -8.17%.
Over the past week, the price has changed by -4.71%, over one month by -3.35%, over three months by -19.59% and over the past year by -8.17%.
Is DORM a buy, sell or hold?
Dorman Products has received a consensus analysts rating of 3.75.
Therefor, it is recommend to hold DORM.
- Strong Buy: 0
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the DORM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 173.5 | 34.4% |
| Analysts Target Price | 173.5 | 34.4% |
| ValueRay Target Price | 123.8 | -4.1% |
DORM Fundamental Data Overview December 03, 2025
Market Cap USD = 4.00b (4.00b USD * 1.0 USD.USD)
P/E Trailing = 16.2839
P/E Forward = 13.624
P/S = 1.8796
P/B = 2.7267
P/EG = 1.37
Beta = 0.881
Revenue TTM = 2.13b USD
EBIT TTM = 360.7m USD
EBITDA TTM = 416.2m USD
Long Term Debt = 421.1m USD (from longTermDebt, last quarter)
Short Term Debt = 34.4m USD (from shortTermDebt, last quarter)
Debt = 554.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 499.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.50b USD (4.00b + Debt 554.8m - CCE 55.5m)
Interest Coverage Ratio = 11.67 (Ebit TTM 360.7m / Interest Expense TTM 30.9m)
FCF Yield = 2.34% (FCF TTM 105.4m / Enterprise Value 4.50b)
FCF Margin = 4.96% (FCF TTM 105.4m / Revenue TTM 2.13b)
Net Margin = 11.62% (Net Income TTM 247.1m / Revenue TTM 2.13b)
Gross Margin = 41.88% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.24b) / Revenue TTM)
Gross Margin QoQ = 44.40% (prev 40.58%)
Tobins Q-Ratio = 1.76 (Enterprise Value 4.50b / Total Assets 2.55b)
Interest Expense / Debt = 1.30% (Interest Expense 7.21m / Debt 554.8m)
Taxrate = 23.52% (23.5m / 99.9m)
NOPAT = 275.8m (EBIT 360.7m * (1 - 23.52%))
Current Ratio = 2.94 (Total Current Assets 1.52b / Total Current Liabilities 516.7m)
Debt / Equity = 0.37 (Debt 554.8m / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = 1.20 (Net Debt 499.3m / EBITDA 416.2m)
Debt / FCF = 4.74 (Net Debt 499.3m / FCF TTM 105.4m)
Total Stockholder Equity = 1.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.68% (Net Income 247.1m / Total Assets 2.55b)
RoE = 17.93% (Net Income TTM 247.1m / Total Stockholder Equity 1.38b)
RoCE = 20.05% (EBIT 360.7m / Capital Employed (Equity 1.38b + L.T.Debt 421.1m))
RoIC = 14.96% (NOPAT 275.8m / Invested Capital 1.84b)
WACC = 7.69% (E(4.00b)/V(4.55b) * Re(8.62%) + D(554.8m)/V(4.55b) * Rd(1.30%) * (1-Tc(0.24)))
Discount Rate = 8.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.16%
[DCF Debug] Terminal Value 77.29% ; FCFE base≈134.0m ; Y1≈143.9m ; Y5≈175.9m
Fair Price DCF = 90.24 (DCF Value 2.76b / Shares Outstanding 30.6m; 5y FCF grow 8.22% → 3.0% )
EPS Correlation: 70.33 | EPS CAGR: 19.82% | SUE: 0.54 | # QB: 0
Revenue Correlation: 90.22 | Revenue CAGR: 8.66% | SUE: -0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.15 | Chg30d=-0.030 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=9.45 | Chg30d=-0.042 | Revisions Net=+1 | Growth EPS=+7.1% | Growth Revenue=+5.3%
P/E Trailing = 16.2839
P/E Forward = 13.624
P/S = 1.8796
P/B = 2.7267
P/EG = 1.37
Beta = 0.881
Revenue TTM = 2.13b USD
EBIT TTM = 360.7m USD
EBITDA TTM = 416.2m USD
Long Term Debt = 421.1m USD (from longTermDebt, last quarter)
Short Term Debt = 34.4m USD (from shortTermDebt, last quarter)
Debt = 554.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 499.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.50b USD (4.00b + Debt 554.8m - CCE 55.5m)
Interest Coverage Ratio = 11.67 (Ebit TTM 360.7m / Interest Expense TTM 30.9m)
FCF Yield = 2.34% (FCF TTM 105.4m / Enterprise Value 4.50b)
FCF Margin = 4.96% (FCF TTM 105.4m / Revenue TTM 2.13b)
Net Margin = 11.62% (Net Income TTM 247.1m / Revenue TTM 2.13b)
Gross Margin = 41.88% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.24b) / Revenue TTM)
Gross Margin QoQ = 44.40% (prev 40.58%)
Tobins Q-Ratio = 1.76 (Enterprise Value 4.50b / Total Assets 2.55b)
Interest Expense / Debt = 1.30% (Interest Expense 7.21m / Debt 554.8m)
Taxrate = 23.52% (23.5m / 99.9m)
NOPAT = 275.8m (EBIT 360.7m * (1 - 23.52%))
Current Ratio = 2.94 (Total Current Assets 1.52b / Total Current Liabilities 516.7m)
Debt / Equity = 0.37 (Debt 554.8m / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = 1.20 (Net Debt 499.3m / EBITDA 416.2m)
Debt / FCF = 4.74 (Net Debt 499.3m / FCF TTM 105.4m)
Total Stockholder Equity = 1.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.68% (Net Income 247.1m / Total Assets 2.55b)
RoE = 17.93% (Net Income TTM 247.1m / Total Stockholder Equity 1.38b)
RoCE = 20.05% (EBIT 360.7m / Capital Employed (Equity 1.38b + L.T.Debt 421.1m))
RoIC = 14.96% (NOPAT 275.8m / Invested Capital 1.84b)
WACC = 7.69% (E(4.00b)/V(4.55b) * Re(8.62%) + D(554.8m)/V(4.55b) * Rd(1.30%) * (1-Tc(0.24)))
Discount Rate = 8.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.16%
[DCF Debug] Terminal Value 77.29% ; FCFE base≈134.0m ; Y1≈143.9m ; Y5≈175.9m
Fair Price DCF = 90.24 (DCF Value 2.76b / Shares Outstanding 30.6m; 5y FCF grow 8.22% → 3.0% )
EPS Correlation: 70.33 | EPS CAGR: 19.82% | SUE: 0.54 | # QB: 0
Revenue Correlation: 90.22 | Revenue CAGR: 8.66% | SUE: -0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.15 | Chg30d=-0.030 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=9.45 | Chg30d=-0.042 | Revisions Net=+1 | Growth EPS=+7.1% | Growth Revenue=+5.3%
Additional Sources for DORM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle